The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study

Prothrombin induced by vitamin K absence II (PIVKA-II) has recently been validated internationally as a diagnostic biomarker for hepatocellular carcinoma (HCC), as part of the GALAD model. However, its role as a treatment response biomarker has been less well explored. We, therefore, undertook a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagar, Vandana M., Herring, Kathyrn, Curbishley, Stuart, Hodson, James, Fletcher, Peter, Karkhanis, Salil, Mehrzad, Homoyon, Punia, Pankaj, Shah, Tahir, Shetty, Shishir, Ma, Yuk Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629402/
https://www.ncbi.nlm.nih.gov/pubmed/34853657
http://dx.doi.org/10.18632/oncotarget.28136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629402/
https://www.ncbi.nlm.nih.gov/pubmed/34853657
http://dx.doi.org/10.18632/oncotarget.28136

Ejemplares similares